Catalent Leader Invited to Chair Discussions on Optimizing Clinical Operation Delivery at China Clinical Trials Partnerships Conference
Somerset, NJ – March 26, 2013 — As construction of Catalent’s new clinical trials facility starts in the same city, Mr. Gerry Hepburn, Chief Operating Officer of Catalent’s Clinical Supply Services business, will host and mediate afternoon discussions on the first day of China Clinical Trials Partnerships 2013 in Shanghai, China.
Also on March 27, Mr. Hepburn will lead a discussion on “The impact of e-clinical solutions on clinical trial planning and supply chain management” at the two-day conference. Effective planning of clinical trials, and the management of trials materials through a global supply chain, can be significantly enhanced through the adoption of e-clinical solutions. They can also have a significant positive impact on the cost and effectiveness of trials, yielding better data and driving faster outcomes. Following a presentation by Mr. Hepburn, panelists, including representatives from Catalent’s global alliance partner PAREXEL, will discuss key challenges in planning and supply chain management, the impact of e-clinical solutions implementation on clinical pharmaceutical companies, experiences in selecting best e-solutions providers and the relationships between selection of the latest e-clinical technologies and industry guidance and regulation.
Catalent and ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, recently formed a joint-venture called Catalent (Shanghai) Clinical Trial Supplies Co., Ltd. Following the announcement, construction activities have begun at the new 31,000 sq ft facility which will be the first in China to provide end-to-end solutions for clinical trial supplies, including comparator sourcing, primary and secondary packaging and labeling, and storage and distribution.
Catalent now has facilities in the US, Europe and Asia/Pacific regions, and more than 60 depots covering 6 continents. Catalent Clinical Supply Services has a robust network built around the most complete integrated service offerings for pharmaceuticals in clinical trial phases I-IV. Catalent provides the reassurance of reliable supply and deep expertise in global supply chain and clinical project management, speeding trial outcomes. For more information on Catalent’s integrated pharma resources and project management for clinical supply visit www.catalent.com
Gerry Hepburn has 30 years of experience in engineering, operations and management. He is responsible for Catalent’s global clinical trials supply chain business, including comparator sourcing, clinical packaging, storage, distribution and returns. He holds a diploma in Physics and Electronics from Glasgow Caledonian University.
China Clinical Trials Partnerships 2013 takes place from March 27 – 28, 2013 at the Renaissance Shanghai Yangtze Hotel, Shanghai, China. Mr. Hepburn is to chair discussions on the afternoon of the first day of the conference and his presentation on e-clinical solutions is scheduled to start at 4.30 pm. For more information visit www.cctpsummit.com
Catalent Pharma Solutions is the global leader in development solutions and advanced drug delivery technologies, providing world-wide clinical and commercial supply capabilities for drugs, biologics and consumer health products. With over 75 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable product supply. Catalent employs approximately 9,000 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and generates more than $1.7 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit www.catalent.com .